International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 4

Slow Binding Deserves More Weight in Natural Product Lead Selection When Potency, Residence Time, and Functional Duration Tell Different Stories
Download PDF


, ,
  1. Department of Slow Binding Kinetics and Lead Prioritization, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
  2. Department of Functional Duration and Residence Time Pharmacology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Citation
Vancouver
Rodrigues A, Martins T, Lopes B. Slow Binding Deserves More Weight in Natural Product Lead Selection When Potency, Residence Time, and Functional Duration Tell Different Stories. Int J Pharm Phytopharmacol Res. 2025;15(4):94-102. https://doi.org/10.51847/5eEkiGuPXs
APA
Rodrigues, A., Martins, T., & Lopes, B. (2025). Slow Binding Deserves More Weight in Natural Product Lead Selection When Potency, Residence Time, and Functional Duration Tell Different Stories. International Journal of Pharmaceutical And Phytopharmacological Research, 15(4), 94-102. https://doi.org/10.51847/5eEkiGuPXs
Download citation:   EndNote   RIS
Article Link:
Downloads: 23
Views: 74
Abstract

Natural-product lead selection is often dominated by equilibrium potency, even when candidates differ substantially in how rapidly they associate with a target, how slowly they dissociate, and how long their pharmacological effects persist after extracellular drug concentrations decline. This creates a ranking problem: a compound that appears weaker at a conventional endpoint may sustain target engagement or function longer than a nominally more potent comparator, whereas a long residence time may also fail to translate because of exposure limitations, rapid target turnover, weak rebinding, or cellular context. This article develops an original pharmacological framework for interpreting such discordance. The analysis separates equilibrium potency, association rate, dissociation rate, residence time, functional duration, rebinding, exposure, and target turnover rather than treating them as interchangeable indicators of binding strength. It argues that slow binding deserves additional lead-selection weight only when the kinetic difference is experimentally credible, survives functional testing, and remains pharmacologically meaningful in the relevant biological system. Natural-product examples illustrate why stereochemistry, macrocyclic architecture, conformational transitions, and multistate binding can generate kinetic behavior not captured by equilibrium potency alone. The proposed framework is therefore conditional rather than score based: kinetics can upgrade, downgrade, or leave unchanged a potency-led ranking depending on mechanistic and contextual evidence. The approach does not establish a universal residence-time threshold, prospective ranking accuracy, therapeutic superiority, or implementation readiness. Its purpose is to make kinetic evidence proportionate to what has actually been measured and to identify when discordant potency and duration warrant deeper mechanistic investigation.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 4
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.